| Primary |
| Bladder Cancer |
63.6% |
| Product Used For Unknown Indication |
10.9% |
| Bladder Transitional Cell Carcinoma |
7.1% |
| Haematuria |
2.2% |
| Bladder Cancer Recurrent |
1.6% |
| Carcinoma In Situ Of Bladder |
1.6% |
| Drug Use For Unknown Indication |
1.6% |
| Tuberculin Test |
1.6% |
| Tuberculosis |
1.6% |
| Bladder Cancer Stage 0, With Cancer In Situ |
1.1% |
| Bladder Cancer Stage I, Without Cancer In Situ |
1.1% |
| Herpes Zoster |
1.1% |
| Transitional Cell Carcinoma |
1.1% |
| Bladder Disorder |
0.5% |
| Bladder Transitional Cell Carcinoma Stage I |
0.5% |
| Carcinoma In Situ |
0.5% |
| Neoplasm Malignant |
0.5% |
| Neoplasm Prostate |
0.5% |
| Recurrent Cancer |
0.5% |
| Rheumatoid Arthritis |
0.5% |
|
| Pyrexia |
14.1% |
| Cystitis |
11.5% |
| Urinary Tract Infection |
10.3% |
| Bladder Cancer Recurrent |
9.0% |
| Tuberculosis |
6.4% |
| Pseudomonas Infection |
5.1% |
| Contracted Bladder |
3.8% |
| Epididymitis Tuberculous |
3.8% |
| Haematuria |
3.8% |
| Lethargy |
3.8% |
| Reiter's Syndrome |
3.8% |
| Sepsis |
3.8% |
| Adverse Event |
2.6% |
| Cerebrovascular Accident |
2.6% |
| Disseminated Tuberculosis |
2.6% |
| Hepatosplenomegaly |
2.6% |
| Malaise |
2.6% |
| Neoplasm Recurrence |
2.6% |
| Ocular Hyperaemia |
2.6% |
| Orchitis |
2.6% |
|
| Secondary |
| Hiv Infection |
26.6% |
| Tuberculosis |
13.3% |
| Immunisation |
12.5% |
| Product Used For Unknown Indication |
12.2% |
| Antiretroviral Therapy |
9.1% |
| Tuberculin Test |
9.1% |
| Bladder Cancer |
6.5% |
| Maternal Exposure During Pregnancy |
2.3% |
| Drug Exposure During Pregnancy |
1.9% |
| Type 2 Diabetes Mellitus |
1.5% |
| Bladder Transitional Cell Carcinoma |
1.1% |
| Bladder Cancer Recurrent |
0.8% |
| Hiv Infection Cdc Group Iii |
0.8% |
| Retroviral Infection |
0.8% |
| Rheumatoid Arthritis |
0.8% |
| Carcinoma In Situ Of Bladder |
0.4% |
| Recurrent Cancer |
0.4% |
|
| Lymphadenopathy |
14.5% |
| Wrong Drug Administered |
14.5% |
| Immune Reconstitution Syndrome |
12.7% |
| Haemorrhage |
7.3% |
| Encephalitis |
5.5% |
| Lymphadenitis |
5.5% |
| Underdose |
5.5% |
| Bovine Tuberculosis |
3.6% |
| Chemical Cystitis |
3.6% |
| Premature Baby |
3.6% |
| Tendonitis |
3.6% |
| Tuberculin Test Positive |
3.6% |
| Tuberculosis |
3.6% |
| Arthralgia |
1.8% |
| Atypical Mycobacterial Lymphadenitis |
1.8% |
| Bladder Perforation |
1.8% |
| Brain Oedema |
1.8% |
| Drug Exposure During Pregnancy |
1.8% |
| Ear Infection |
1.8% |
| Epididymitis |
1.8% |
|
| Concomitant |
| Prophylaxis |
21.5% |
| Rheumatoid Arthritis |
10.1% |
| Drug Toxicity Prophylaxis |
7.6% |
| Embolism Venous |
7.6% |
| Supplementation Therapy |
7.6% |
| Acquired Immunodeficiency Syndrome |
6.3% |
| Bladder Cancer |
6.3% |
| Drug Use For Unknown Indication |
6.3% |
| Immunisation |
5.1% |
| Foetal Distress Syndrome |
3.8% |
| Anaemia |
2.5% |
| Anaemia Of Malignant Disease |
2.5% |
| Hiv Infection |
2.5% |
| Prostate Cancer Stage Ii |
2.5% |
| Ankylosing Spondylitis |
1.3% |
| Benign Prostatic Hyperplasia |
1.3% |
| Bronchiolitis |
1.3% |
| Chancroid |
1.3% |
| Constipation |
1.3% |
| Epilepsy |
1.3% |
|
| Anticoagulation Drug Level Above Therapeutic |
15.8% |
| Rash Erythematous |
13.2% |
| Vomiting |
10.5% |
| White Blood Cell Count Increased |
7.9% |
| Loss Of Consciousness |
5.3% |
| Pseudomembranous Colitis |
5.3% |
| Sleep Talking |
5.3% |
| Stomatitis |
5.3% |
| Angina Unstable |
2.6% |
| Drug Ineffective For Unapproved Indication |
2.6% |
| Frequent Bowel Movements |
2.6% |
| Influenza Like Illness |
2.6% |
| Neutropenia |
2.6% |
| Pancytopenia |
2.6% |
| Platelet Count Increased |
2.6% |
| Pneumonia Bacterial |
2.6% |
| Premature Separation Of Placenta |
2.6% |
| Staphylococcal Infection |
2.6% |
| Sudden Infant Death Syndrome |
2.6% |
| Viral Upper Respiratory Tract Infection |
2.6% |
|
